Expert Opinion on Drug Metabolism and Toxicology

Caco-2 cell permeability assays to measure drug absorption
pp. 175-185(11)
Authors: van Breemen, Richard B; Li, Yongmei

Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1
pp. 187-202(16)
Authors: Roos, Peter H; Bolt, Hermann M

The influence of long-term treatment with psychotropic drugs on cytochrome P450: the involvement of different mechanisms
pp. 203-217(15)
Authors: Daniel, Włladyslława Anna

Metabolism of ATP-binding cassette drug transporter inhibitors: complicating factor for multidrug resistance
pp. 219-232(14)
Authors: Cnubben, Nicole HP; Wortelboer, Heleen M; van Zanden, Jelmer J; Rietjens, Ivonne MCM; van Bladeren, Peter J

Expression and function of multidrug resistance transporters at the blood–brain barriers
pp. 233-246(14)
Author: Scherrmann, Jean-Michel

Gene expression profiling for pharmaceutical safety assessment
pp. 247-260(14)
Authors: Huby, Russell; Tugwood, Jonathan D

Genotoxicity screening: the slow march to the future
pp. 261-268(8)
Author: Walmsley, Richard M

Clinical pharmacology of etoricoxib
pp. 269-282(14)
Authors: Capone, Marta L; Tacconelli, Stefania; Patrignani, Paola

Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction
pp. 283-293(11)
Authors: Francis, Sharron H; Corbin, Jackie D

Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor
pp. 295-301(7)
Author: Sommer, Frank

Computational prediction of human drug metabolism
pp. 303-324(22)
Authors: Ekins, Sean; Andreyev, Sergey; Ryabov, Andy; Kirillov, Eugene; Rakhmatuli, Eugene A; Bugrim, Andrej; Nikolskaya, Tatiana

The rise of PAMPA
pp. 325-342(18)
Author: Avdeef, Alex